Dr. Kytai Nguyen
Dr. Nguyen and the UTA NIH T32 fellows adapt to challenges by taking the meetings online.
Cynthia Co delivered a presentation on Carbon Nanotubes and their application in the field of Biomedical Engineering.
Ann Phillips delivered a presentation covering the progress of her research.
The NIH T32 Summer Symposium covered many topics relating to biomedical engineering. The discussion was delivered via Teams. Adam Germain talked about communication between hospitals and biomedical engineers. Alan Taylor talked about the risks and toxicology of Nanotechnology. Annie Phillips talked about nanotechnology's application in everyday life. Cynthia Co talked about ethics in relation to nanotechnology. Karla Perez talked about job opportunities in the field of nanotechnology. Lenaiya Kydd delivered a presentation on Leaders in NanoTechnology. Luis Soto-Garcia spoke about nanotechnology and disease. Finally, Victoria Messerschmidt talked about emerging nanotechnology.
Doctoral student Luis Soto spoke on the topic of Nanotechnology's potential support in the fight against SARS Covid 2.
Dr. Nguyen and the UTA NIH T32 fellows adapt to challenges by taking the meetings online.
Aneetta Kuriakose introduces her research topic and discusses her yearly progress. Aneetta is working to prevent the complications such as restenosis after percutaneous coronary interventions by promoting regeneration/accelerated healing of injured endothelial layer using nanotechnology.
Aneetta Kuriakose and Victoria Messerschmidt pause to discuss what they have learned at the meeting. NIH fellows were tasked with teaching each other about the following topics: Emerging nanotechnology landscape (Victoria M.), Nanotechnology risk and toxicology management (Katherine M.), Interactions btw engineers with hospital and companies (Aneetta K.), Entrepreneurship and intellectual property (Elizabeth L.), and Leadership development (Le’Naiya K.)
Elizabeth Lyde describes how she is working to evaluate the effects of cardiovascular risk factors on brain networks using functional Near-Infrared Spectroscopy (fNIRS) and eventual integration of targeted antioxidant nanoparticles to improve systemic and brain blood flow.
Katherine Copeland explains her research progress on her idea to create a therapeutic alternative to non-surgical patients suffering from hypertrophic obstructive cardiomyopathy using nanotechnology to the NIH mentors and other invited guests.